Facing autismA focus on diagnosis, current controversies and proven treatments. First oral MS drug approved in U.S.Fingolimod (Gilenya, Novartis) offers patients an alternative to injectable therapies. Two Canadian centres win stroke care honours Calgary, Toronto Rehab earn new accreditation Stroke costs in Canada found to be double previous estimates Price-tag for first six months after ischemic stroke: close to $50,000 Apixaban reduces AF patients’ stroke risk compared with ASA Agent tested in atrial fibrillation patients who are unsuitable for warfarin therapy Daughters more prone to depression than sons when caring for parent with stroke Supports needed for family members who are “critical” to stroke recovery: MD Community program reduces cardiovascular hospitalization rate Teaching volunteer peer educators about risk factors and how to reduce them proves effective in Canadian study Younger stroke patients show evidence of previous damage Under-50s who have had ‘silent’ strokes are at higher risk for another stroke; MRIs recommended for all young stroke patients Canadians urge world stroke agenda General public can help motivate prevention in others and be trained in rehab therapies Hitting the links for brain injury research First Previous 51 52 53 54 55 Next Last
